Cargando…
Uptake of pneumococcal vaccination in older people in northern Israel
The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal...
Autores principales: | Eilat-Tsanani, Sophia, Vashitz-Giwnewer, Ayelet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683891/ https://www.ncbi.nlm.nih.gov/pubmed/34976622 http://dx.doi.org/10.1016/j.pmedr.2021.101553 |
Ejemplares similares
-
Occurrence of comorbidities in newly diagnosed type 2 diabetes patients and their impact after 11 years’ follow-up
por: Eilat-Tsanani, Sophia, et al.
Publicado: (2021) -
Community-acquired pneumonia – use of chest x-rays for diagnosis in family practice
por: Eilat-Tsanani, Sophia, et al.
Publicado: (2022) -
The low indexes of metabolism intervention trial (LIMIT): design and baseline data of a randomized controlled clinical trial to evaluate how alerting primary care teams to low metabolic values, could affect the health of patients aged 75 or older
por: Tsabar, Nir, et al.
Publicado: (2018) -
Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study
por: Perniciaro, Stephanie, et al.
Publicado: (2021) -
Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel
por: Weinberger, Daniel M., et al.
Publicado: (2013)